Table 2.
Participant characteristics per Delphi round.
Round 1 | Round 2 | Round 3 | |
---|---|---|---|
n | n (response rate R1) | n (response rate R2) | |
Stakeholder group | |||
Researchers | 85 | 69 (81%) | 52 (75%) |
Parents or caregivers | 32 | 14 (44%) | 8 (57%) |
Health professionals | 47 | 33 (70%) | 18 (55%) |
Policy-makers or funders | 20 | 16 (80%) | 11 (69%) |
Community or organisational stakeholders | 22 | 11 (50%) | 7 (64%) |
Total | 206 | 143 (69%) | 96 (67%) |
Gender | |||
Female | 185 | 127 | 83 |
Male | 21 | 16 | 13 |
Place of residence | |||
Australasia | |||
Australia | 105 | 66 | 45 |
New Zealand | 3 | 3 | 1 |
Fiji | 1 | 1 | 0 |
Europe | |||
United Kingdom | 23 | 21 | 11 |
Ireland | 10 | 4 | 2 |
Netherlands | 5 | 5 | 3 |
Sweden | 5 | 5 | 5 |
Norway | 4 | 3 | 2 |
Bulgaria | 1 | 0 | 0 |
France | 1 | 1 | 1 |
Georgia | 1 | 1 | 1 |
Macedonia | 1 | 1 | 1 |
Moldova | 1 | 0 | 0 |
Poland | 1 | 1 | 1 |
Asia | |||
Israel | 4 | 2 | 1 |
Hong Kong | 1 | 1 | 1 |
Indonesia | 1 | 0 | 0 |
Kazakhstan | 1 | 1 | 0 |
Malaysia | 1 | 1 | 1 |
Singapore | 1 | 1 | 1 |
North America | |||
United States of America | 28 | 22 | 16 |
Canada | 2 | 0 | 0 |
Guatemala | 1 | 0 | 0 |
South America | |||
Brazil | 1 | 0 | 0 |
Africa | |||
South Africa | 3 | 3 | 3 |
R1 = Round 1, R2 = Round 2, R3 = Round 3.